1. Home
  2. VBTX vs GERN Comparison

VBTX vs GERN Comparison

Compare VBTX & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VBTX
  • GERN
  • Stock Information
  • Founded
  • VBTX 2009
  • GERN 1990
  • Country
  • VBTX United States
  • GERN United States
  • Employees
  • VBTX N/A
  • GERN N/A
  • Industry
  • VBTX Major Banks
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VBTX Finance
  • GERN Health Care
  • Exchange
  • VBTX Nasdaq
  • GERN Nasdaq
  • Market Cap
  • VBTX 1.4B
  • GERN 1.5B
  • IPO Year
  • VBTX 2014
  • GERN 1996
  • Fundamental
  • Price
  • VBTX $24.97
  • GERN $1.59
  • Analyst Decision
  • VBTX Strong Buy
  • GERN Buy
  • Analyst Count
  • VBTX 5
  • GERN 11
  • Target Price
  • VBTX $31.20
  • GERN $5.80
  • AVG Volume (30 Days)
  • VBTX 303.4K
  • GERN 14.3M
  • Earning Date
  • VBTX 04-22-2025
  • GERN 05-01-2025
  • Dividend Yield
  • VBTX 3.22%
  • GERN N/A
  • EPS Growth
  • VBTX N/A
  • GERN N/A
  • EPS
  • VBTX 1.95
  • GERN N/A
  • Revenue
  • VBTX $405,539,000.00
  • GERN $76,994,000.00
  • Revenue This Year
  • VBTX $14.51
  • GERN $208.83
  • Revenue Next Year
  • VBTX $6.33
  • GERN $57.49
  • P/E Ratio
  • VBTX $12.74
  • GERN N/A
  • Revenue Growth
  • VBTX 7.36
  • GERN 32386.92
  • 52 Week Low
  • VBTX $18.74
  • GERN $1.46
  • 52 Week High
  • VBTX $31.62
  • GERN $5.34
  • Technical
  • Relative Strength Index (RSI)
  • VBTX 49.18
  • GERN 32.05
  • Support Level
  • VBTX $24.31
  • GERN $1.63
  • Resistance Level
  • VBTX $25.20
  • GERN $1.89
  • Average True Range (ATR)
  • VBTX 0.62
  • GERN 0.11
  • MACD
  • VBTX 0.12
  • GERN 0.03
  • Stochastic Oscillator
  • VBTX 71.35
  • GERN 16.67

About VBTX Veritex Holdings Inc.

Veritex Holdings Inc is engaged in the provision of commercial banking products and services to small to medium-sized businesses and professionals. The bank provides a range of banking services to individual and corporate customers, which include commercial and retail lending, and the acceptance of checking and savings deposits. It offers a suite of online banking solutions, including access to account balances, online transfers, online bill payment and electronic delivery of customer statements, as well as automated teller machines, and banking by telephone, mail and personal appointment. The company's primary sources of revenue are derived from interest and dividends earned on loans, debt and equity securities and other financial instruments.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: